Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Morin

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Biotechniques|February 13, 2019
A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral bloodPawan K Pandoh, Richard D Corbett, Helen McDonald, et al.
Blood|December 31, 2010
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationDamian B Yap, Justin Chu, Tobias Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastomaOlena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Oncoimmunology|August 17, 2017
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphomaJulie S Nielsen, Andrew R Chang, Darin A Wick, et al.
JCO Precision Oncology|September 11, 2020
Temporal Dynamics of Genomic Alterations in a <i>BRCA1</i> Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and IrinotecanHui-Li Wong, Eric Y Zhao, Martin R Jones, et al.
International Journal of Hematology|January 29, 2024
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironmentAlexandre Benoit, Madelyn J Abraham, Sheena Li, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Research|October 2, 2010
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosisK-John J Cheung, Nathalie A Johnson, Joslynn G Affleck, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Biotechniques|February 13, 2019
A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral bloodPawan K Pandoh, Richard D Corbett, Helen McDonald, et al.
Blood|December 31, 2010
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationDamian B Yap, Justin Chu, Tobias Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastomaOlena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Oncoimmunology|August 17, 2017
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphomaJulie S Nielsen, Andrew R Chang, Darin A Wick, et al.
JCO Precision Oncology|September 11, 2020
Temporal Dynamics of Genomic Alterations in a <i>BRCA1</i> Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and IrinotecanHui-Li Wong, Eric Y Zhao, Martin R Jones, et al.
International Journal of Hematology|January 29, 2024
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironmentAlexandre Benoit, Madelyn J Abraham, Sheena Li, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Research|October 2, 2010
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosisK-John J Cheung, Nathalie A Johnson, Joslynn G Affleck, et al.
Pageof 15